These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31843438)

  • 1. Detection of hemodynamic impairment on
    Hara S; Tanaka Y; Ueda Y; Abe D; Hayashi S; Inaji M; Maehara T; Ishii K; Nariai T
    J Clin Neurosci; 2020 Feb; 72():258-263. PubMed ID: 31843438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial coefficient of variation of arterial spin labeling MRI for detecting hemodynamic disturbances measured with
    Hara S; Tanaka Y; Inaji M; Hayashi S; Ishii K; Nariai T; Maehara T
    Neuroradiology; 2022 Apr; 64(4):675-684. PubMed ID: 34499192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with
    Hara S; Tanaka Y; Ueda Y; Hayashi S; Inaji M; Ishiwata K; Ishii K; Maehara T; Nariai T
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):696-702. PubMed ID: 28209582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [
    Fan AP; Khalighi MM; Guo J; Ishii Y; Rosenberg J; Wardak M; Park JH; Shen B; Holley D; Gandhi H; Haywood T; Singh P; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2019 Feb; 50(2):373-380. PubMed ID: 30636572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial spin labeling magnetic resonance imaging at short post-labeling delay reflects cerebral perfusion pressure verified by oxygen-15-positron emission tomography in cerebrovascular steno-occlusive disease.
    Itagaki H; Kokubo Y; Kawanami K; Sato S; Yamada Y; Sato S; Sonoda Y
    Acta Radiol; 2021 Feb; 62(2):225-233. PubMed ID: 32295388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.
    Fan AP; Guo J; Khalighi MM; Gulaka PK; Shen B; Park JH; Gandhi H; Holley D; Rutledge O; Singh P; Haywood T; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2017 Sep; 48(9):2441-2449. PubMed ID: 28765286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
    Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
    J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
    Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
    Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-contrast hemodynamic imaging of Moyamoya disease with MR fingerprinting ASL: A feasibility study.
    Su P; Liu P; Pinho MC; Thomas BP; Qiao Y; Huang J; Welch BG; Lu H
    Magn Reson Imaging; 2022 May; 88():116-122. PubMed ID: 35183659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Apr; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic Impairment Measured by Positron-Emission Tomography Is Regionally Associated with Decreased Cortical Thickness in Moyamoya Phenomenon.
    Lee JJ; Shimony JS; Jafri H; Zazulia AR; Dacey RG; Zipfel GR; Derdeyn CP
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):2037-2044. PubMed ID: 30361434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
    Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease.
    Zhang J; Xia C; Liu Y; Qian W; Peng W; Liu K; Li L; Zhao F; Li Z
    Medicine (Baltimore); 2018 Oct; 97(41):e12768. PubMed ID: 30313089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging.
    Wang R; Yu S; Alger JR; Zuo Z; Chen J; Wang R; An J; Wang B; Zhao J; Xue R; Wang DJ
    Eur Radiol; 2014 May; 24(5):1135-44. PubMed ID: 24557051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using arterial spin labeling to measure cerebrovascular reactivity in Moyamoya disease: Insights from simultaneous PET/MRI.
    Zhao MY; Fan AP; Chen DY; Ishii Y; Khalighi MM; Moseley M; Steinberg GK; Zaharchuk G
    J Cereb Blood Flow Metab; 2022 Aug; 42(8):1493-1506. PubMed ID: 35236136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography/magnetic resonance hybrid scanner imaging of cerebral blood flow using (15)O-water positron emission tomography and arterial spin labeling magnetic resonance imaging in newborn piglets.
    Andersen JB; Henning WS; Lindberg U; Ladefoged CN; Højgaard L; Greisen G; Law I
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1703-10. PubMed ID: 26058699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.